O’Connor, O. Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Heavily Pretreated Patients With Hematological Malignancies. Hematol Meeting Rep 2009, 1.